β2-adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 3, 1998, Pages 787-791

  Weir, Tracey D ^b   Mallek, Noa ^b   Sandford, Andrew J ^b   Bai, Tony R ^b   Awadh, Nassar ^b   Fitzgerald, J M ^b   Cockcroft, Don ^b   James, Alan ^b   Liggett, Stephen B ^b   Paré, Peter D ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; AMINO ACID; ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DNA; GLUTAMINE; GLYCINE;

ADULT; ALLELE; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOWN REGULATION; ETHNOLOGY; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; ASIAN; CAUCASIAN; CAUSE OF DEATH; CLASSIFICATION; ETHNIC GROUP; GENE FREQUENCY; GENETIC VARIABILITY; GENETICS; MIDDLE AGED; NEGRO; PREVALENCE; RISK;

ADRENERGIC BETA-AGONISTS; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; AMINO ACIDS; ANTI-ASTHMATIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; ASTHMA; CAUSE OF DEATH; DNA; DOWN-REGULATION; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENOTYPE; GLUTAMINE; GLYCINE; HAPLOTYPES; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PREVALENCE; RECEPTORS, ADRENERGIC, BETA; RISK FACTORS; VARIATION (GENETICS);

EID: 0442288082     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.3.9801035     Document Type: Article

References (24)

1. Crane, J., N. E. Pearce, A. Flatt, C. Burgess, R. Jackson, T. Kwong, M. Ball, and R. Beasley. 1989. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case control study. Lancet 1:917-922.
2. Spitzer, W. O., S. Suissa, P. Ernst, R. I. Horwitz, B. Habbick, D. Cockroft, J.-F. Boivin, M. McNutt, A. S. Buist, and A. S. Rebuck. 1992. Beta agonists and the risk of asthma death in near-fatal asthma. N. Engl. J. Med. 326:501-506.
3. Bai, T. R. 1991. Abnormalities in airway smooth muscle in fatal asthmaa comparison between trachea and bronchus. Am. Rev. Respir. Dis. 143:441-443.
4. Bai, T. R., J. C. W. Mak, and P. J. Barnes. 1992. A comparison of β-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle. Am. J. Respir. Cell Mol. Biol. 6:647-651.
5. Barnes, P. J., M. M. Grunstein, A. R. Leff, and A. J. Woolcock. 1997. Asthma, Vol. 1. Lippincott-Raven, Philadelphia. 985.
6. 2-adrenergic receptor in nocturnal and nonnocturnal asthma. J. Clin. Invest. 95:1635-1641.
7. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 345:1213-1214.
8. Lentes, K. U., W. H. Berretini, M. R. Hoehe, F. Z. Chung, and E. S. Gershon. 1988. A biallelic DNA polymorphism of the human beta-2 adrenergic receptor detected by Ban I Adbr 2. Nucleic Acids Res. 16: 2359.
9. McQuitty, C. K., C. W. Emala, C. A. Hirshman, and M. A. Levine. 1994. Polymorphism in the human beta-2 adrenergic receptor gene detected by restriction endonuclease digestions with Fnu 4HI. Hum. Genet. 93: 225.
10. 2-adrenergic receptor in normal and asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 8:334-339.
11. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33:9414-9419.
12. 2-adrenergic receptor genotypes in signal transduction in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13: 25-33.
13. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J. Biol. Chem. 268:23116-23121.
14. Turner, M. O., S. Crump, G. R. Conteras, S. Vedal, T. R. Bai, and J. M. FitzGerald. 1994. A prospective evaluation of risk factors for near-fatal asthma (NFA): clinical characteristics (abstract). Am. J. Respir. Crit. Care Med. 149(4):A192.
15. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning. A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
16. Cooper, C. S., and M. R. Stratton. 1991. Extraction and enzymatic amplification of DNA from paraffin-embedded specimens. In C. Matthew, editor. Methods in Molecular Biology, Vol. 9: Protocols in Human Molecular Genetics. Humana Press, Clifton, NJ. 133-140.
17. 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 93:10483-10488.
18. Martinez, F. D., P. E. Graves, M. Baldini, S. Solomon, and R. Erickson. 1997. Association between genetic polymorphisms of the beta-2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J. Clin. Invest. 100:3184-3188.
19. 2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J. Allergy Clin. Immunol. 100:251-265.
20. Robertson, C. F., A. R. Rubinfeld, and G. Bowes. 1992. Pediatric asthma deaths in Victoria: the mild are at risk. Pediatr. Pulmonol. 13:95-100.
21. Strunk, R. C. 1993. Death due to asthma: new insights into sudden unexpected deaths, but the focus remains on prevention. Am. Rev. Respir. Dis. 148:550-552.
22. Schenker, M. B., E. B. Gold, R. L. Lopez, and J. J. Beaumont. 1993. Asthma mortality in California, 1960-1989: demographic patterns and occupational associations. Am. Rev. Respir. Dis. 147:1454-1460.
23. Carr, W., L. Zeitel, and K. Weiss. 1992. Variations in asthma hospitalizations and deaths in New York City. Am. J. Pub. Health. 82:59-65.
24. Gerstman, B. B., L. A. Bosco, D. K. Tomita, T. P. Gross, and M. M. Shaw. 1989. Prevalence and treatment of asthma in the Michigan Medicaid patient population younger than 45 years, 1980-1986. J. Allergy Clin. Immunol. 83:1032-1039.